Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Concert Pharmaceutic (NQ: CNCE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Concert Pharmaceutic

< Previous 1 2 3 4 5 Next >
Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata
From Concert Pharmaceuticals, Inc.
Via Business Wire
CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Concert Pharmaceuticals Stock Rocketed Higher This Week
The company is changing hands in a deal worth at least $576 million. 
Via The Motley Fool
CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE
From Kahn Swick & Foti, LLC
Via Business Wire
India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones
Via Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Concert Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
Concert Pharma: Q3 Earnings Insights
Concert Pharma (NASDAQ:CNCE) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday. 
Via Benzinga
CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
From Concert Pharmaceuticals
Via Business Wire
Recap: Concert Pharma Q2 Earnings
  Concert Pharma (NASDAQ:CNCE) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Is Ardelyx is A Buy After Slip in Early 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them 
Via MarketBeat
Exposures Product Safety
Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference
From Concert Pharmaceuticals
Via Business Wire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022
From Concert Pharmaceuticals, Inc.
Via Business Wire
Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
From Concert Pharmaceuticals, Inc.
Via Business Wire
Bridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia Areata
From Concert Pharmaceuticals, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
Concert Pharmaceuticals Announces That Results From CTP-543 THRIVE‑AA1 Phase 3 Trial in Patients With Alopecia Areata Selected for Late Breaking Presentation at EADV Congress
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals Announces Exercise of Warrants Under Existing Financing Arrangement
From Concert Pharmaceuticals, Inc.
Via Business Wire
Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results
From Concert Pharmaceuticals, Inc.
Via Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.